Source: Eur Respir J 2016; 48: 1127-1136
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nagaraj Chandran, Tang Bi, Nagy Bence M., Papp Rita, Jain Pritesh P., Marsh Leigh M., Meredith Andrea L., Ghanim Bahil, Klepetko Walter, Kwapiszewska Grazyna, Weir E. Kenneth, Olschewski Horst, Olschewski Andrea. Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension. Eur Respir J 2016; 48: 1127-1136

Member's Comments

No comment yet.

Related content which might interest you: Potassium channels in pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 1167-1177 Year: 2015 SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs Source: Eur Respir J 2001; 17: 20-26 Year: 2001 Ca2+-activated K+ channel openers cause epithelium and endothelium-dependent relaxation in pulmonary tissue Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Loss of response to calcium channel blockers after long-term follow up in idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 53 (6) 1800965; 10.1183/13993003.00965-2018 Year: 2019 KCNK3 channel inactivation leads to pulmonary vascular alterations in rat Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 33: 1354-1360 Year: 2009 Stable prostacyclin analogues treprostinil and iloprost activates KCa and two-pore domain TASK-1 channels in human pulmonary artery smooth muscle cells Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats Source: Eur Respir J 2003; 21: 862-865 Year: 2003 The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade Source: Eur Respir J, 50 (6) 1701141; 10.1183/13993003.01141-2017 Year: 2017 Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 1504-1512 Year: 2008 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020 Year: 2021 Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Kv1.5 channels and endothelium-dependent relaxation are downregulated by miR-1 in rat pulmonary arteries. Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020 Year: 2020 MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019